Kalbe Farma Tbk vs Charlie Hospital Semarang Tbk. — how do they compare? Kalbe Farma Tbk trades at Rp800 (market cap 37.45T, 41.79M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp310 (market cap 816.2B, 25.44M 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 45.9× Charlie Hospital Semarang Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (41.79M versus 25.44M). Which is the better fit depends on your goals.
| KLBF | RSCH | |
|---|---|---|
Market Cap | 37.45T | 816.2B |
Volume | 41.79M | 25.44M |
Lot | 417.89K | 254.36K |
Turnover | 33.46B | 7.84B |
Average Price | 800.79 | 308.07 |
Value | 33.46B | 7.84B |
Indicative Equilibrium Price | 800 | 310 |
Indicative Equilibrium Volume | 18.3K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →